Epigallocatechin-3-gallate (EGCG): a potential molecule for the development of therapeutics against emerging SARS-CoV-1, MERS-CoV and SARS-CoV-2 coronaviruses

Publication date: Available online 27 May 2021Source: Journal of Global Antimicrobial ResistanceAuthor(s): Jeswin Joseph, T. Karthika, V.R. Akshay Das, V. Stalin Raj
Source: Journal of Global Antimicrobial Resistance - Category: Infectious Diseases Source Type: research